美国老年人群经导管与外科主动脉瓣置换趋势
该研究分析2012至2019年美国医疗保险受益人数据,发现主动脉瓣置换(AVR)总量增加约60%,其中经导管主动脉瓣置换(TAVR)大幅上升而外科主动脉瓣置换(SAVR)下降。全体AVR患者1年死亡率从11.9%降至9.4%,出院回家比例从24.2%升至54.7%。
要点
- TAVR扩大适应证后,老年AVR总量增加约60%,TAVR取代部分SAVR。
- 全体AVR患者1年死亡率从11.9%降至9.4%,调整后年变化OR为0.94。
- AVR后出院回家比例从24.2%升至54.7%,主要由TAVR驱动。
核心结论
- TAVR的出现使老年AVR总量增加约60%,且整体AVR结局改善。
研究设计与样本
- 基于2012至2019年美国医疗保险受益人数据库的回顾性分析,评估TAVR和SAVR病例量、人口学、合并症、1年死亡率和出院去向。
主要发现
- 每10万受益人年中,AVR从107例增至156例,TAVR从19例增至101例,SAVR从88例降至54例。
- 全体AVR患者中位年龄从77岁(IQR 71-83)变为78岁(IQR 72-84),TAVR从中位84岁(IQR 79-88)降至81岁(IQR 75-86),SAVR从中位76岁(IQR 71-81)降至72岁(IQR 68-77)。
- 全体AVR患者1年死亡率从11.9%降至9.4%;调整后1年死亡率年变化OR:TAVR 0.93(95%CI 0.92-0.94),SAVR 0.98(95%CI 0.97-0.99),全体AVR 0.94(95%CI 0.93-0.95)。
- AVR后出院回家比例从24.2%升至54.7%,主要由TAVR后回家出院增加驱动。
临床怎么用
- 在老年主动脉瓣疾病患者中,TAVR应用增加与AVR总量上升及整体结局改善相关,支持在适应证扩大后更广泛地评估AVR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent trends, including survival beyond 30 days, in aortic valve replacement (AVR) following the expansion of indications for transcatheter aortic valve replacement (TAVR) are not well-understood. OBJECTIVES: The authors sought to characterize the trends in characteristics and outcomes of patients undergoing AVR. METHODS: The authors analyzed Medicare beneficiaries who underwent TAVR and SAVR in 2012 to 2019. They evaluated case volume, demographics, comorbidities, 1-year mortality, and discharge disposition. Cox proportional hazard models were used to assess the annual change in outcomes. RESULTS: Per 100,000 beneficiary-years, AVR increased from 107 to 156, TAVR increased from 19 to 101, whereas SAVR declined from 88 to 54. The median [interquartile range] age remained similar from 77 [71-83] years to 78 [72-84] years for overall AVR, decreased from 84 [79-88] years to 81 [75-86] years for TAVR, and decreased from 76 [71-81] years to 72 [68-77] years for SAVR. For all AVR patients, the prevalence of comorbidities remained relatively stable. The 1-year mortality for all AVR decreased from 11.9% to 9.4%. Annual change in the adjusted odds of 1-year mortality was 0.93 (95% CI: 0.92-0.94) for TAVR and 0.98 (95% CI: 0.97-0.99) for SAVR, and 0.94 (95% CI: 0.93-0.95) for all AVR. Patients discharged to home after AVR increased from 24.2% to 54.7%, primarily driven by increasing home discharge after TAVR. CONCLUSIONS: The advent of TAVR has led to about a 60% increase in overall AVR in older adults. Improving outcomes in AVR as a whole following the advent of TAVR with increased access is a reassuring trend.
引用
- Mori M, Gupta A, Wang Y, et al. Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States. J Am Coll Cardiol. 2021. PMID: 34823659. doi:10.1016/j.jacc.2021.09.855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。